Nonagen Bioscience
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3680 Wilshire Blvd Ste P04, Los Angeles,...Phone Number
(323) 205-6160Website
www.nonagen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nonagen Bioscience
Nonagen Bioscience is dedicated to discovering and developing innovative diagnostics for human diseases, with a focus on transforming research findings into advanced diagnostic tools. Their flagship product, Oncuria, is a multiplex protein immunoassay designed to aid in the diagnosis and monitoring of bladder cancer, as well as predicting patient responses to BCG therapy. The company aims to provide healthcare professionals with superior diagnostic capabilities to enhance disease management. Their target clients include medical professionals and institutions involved in the diagnosis and treatment of bladder cancer.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nonagen Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Nonagen Bioscience has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Nonagen Bioscience launches new products
Check out if Nonagen Bioscience is spiking on competitors!
Website visits: Recent activity has been detected on your website
Nonagen Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Nonagen Bioscience
Click to see if Nonagen Bioscience had a recent Job posting/layoffs
Earning: See what the market has to say on Nonagen Bioscience recently announced quarterly report
Funding: Get notified immidiatlly once Nonagen Bioscience has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Nonagen Bioscience
Compare insights from companies similar to Nonagen Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Nonagen Bioscience
<$5M
1-10
Private
-
2011
N/A
Company Profile Activity
Activity Insights
Nonagen Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nonagen Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nonagen Bioscience.
Nonagen Bioscience Tech Stack
A closer look at the technologies used by Nonagen Bioscience
Nonagen Bioscience News & Media
Nonagen Bioscience announces Timothy "TJ" Johnson as Executive Chair of Nonagen Bioscience Corporation
LOS ANGELES, April 27, 2023 /PRNewswire/ -- Nonagen Bioscience, a cancer diagnostics company, today announced that Timothy "TJ" Johnson has been named Executive Chair of the Nonagen Bioscience Corporation. Mr. Johnson has nearly 30 years of executive leadership experience in the life...DiaCarta Announces Successful Completion of Oncuria® Validation Study with Nonagen Bioscience
DiaCarta Starts to Receive Samples for Oncuria® Bladder Cancer Test at its CLIA LabNonagen Bioscience announces CE mark for Oncuria® bladder cancer diagnostic
LOS ANGELES, June 16, 2022 /PRNewswire/— Nonagen Bioscience, a cancer diagnostics company, today announced CE marking for its Oncuria® immunoassay for bladder cancer. Nonagen Bioscience now has CE marking for its Oncuria® bladder cancer immunoassay, setting the stage for European sales....Nonagen Bioscience announces Wayne Hogrefe, PhD as chief operating officer (COO)
LOS ANGELES, June 7, 2022 /PRNewswire/ -- Nonagen Bioscience, a cancer diagnostics company, today announced that Wayne Hogrefe, PhD, has been named COO. Dr. Hogrefe has more than 30 years of experience in the diagnostics industry, including research and assay development for vaccine...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nonagen Bioscience
Sign Up For FreeTo access detailed company insights
Nonagen Bioscience is dedicated to discovering and developing innovative diagnostics for human diseases, with a focus on transforming research findings into advanced diagnostic tools. Their flagship product, Oncuria, is a multiplex protein immunoassay designed to aid in the diagnosis and monitoring of bladder cancer, as well as predicting patient r... Read More
